4 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) Ustekinumab, Placebo, Glucorticoid Taper Regimen - Takayasu Arteritis | Phase 3 | Terminated | Janssen Pharmaceutical K.K. | 14 | 2021-09-15 | 2025-04-29 |
| Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA Sarilumab SAR153191, Sarilumab matching placebo, Prednisone - Giant Cell Arteritis | Phase 3 | Terminated | Sanofi | 83 | 2018-11-20 | 2022-03-28 |
| Giant Cell Arteritis and Anakinra Trial PLACEBO, ANAKINRA - Giant Cell Arteritis | Phase 3 | Terminated | University Hospital, Caen | 30 | 2017-05-11 | 2026-04-02 |
| Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis Sirukumab, Placebo to match sirukumab, Prednisone - Giant Cell Arteritis | Phase 3 | Terminated | GlaxoSmithKline | 161 | 2015-10-16 | 2019-07-31 |
Giant Cell Arteritis (3) · Takayasu Arteritis (1)
Cardiovascular Diseases (4) · Skin Diseases (4) · Skin Diseases, Vascular (4) · Skin and Connective Tissue Diseases (4) · Vascular Diseases (4) · Vasculitis (4) · Autoimmune Diseases (3) · Autoimmune Diseases of the Nervous System (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Immune System Diseases (3) · Nervous System Diseases (3) · Vasculitis, Central Nervous System (3)
Prednisone (2) · Interleukin 1 Receptor Antagonist Protein (1) · Ustekinumab (1) · sarilumab (1) · sirukumab (1)
GlaxoSmithKline (1) · Janssen Pharmaceutical K.K. (1) · Sanofi (1) · University Hospital, Caen (1)
France (3) · Australia (2) · Belgium (2) · Germany (2) · Hungary (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Argentina (1) · Bulgaria (1) · Canada (1) · Croatia (1) · Denmark (1)
PMID 32844378, PMID 37840134, PMID 39400109, PMID 40104212, PMID 40483523
2015 (1), 2017 (1)